By Charles Isham, Founder, Physician Data | physician-data.com
For decades, the dominant model of American medical practice was the independent physician. A doctor owned their practice, saw their patients, made their purchasing decisions, and was accessible to vendors through a relatively direct outreach process. The independent practice was the fundamental unit of the healthcare market, and the entire infrastructure of healthcare B2B marketing was built around reaching it.
That model is disappearing, and the pace of its disappearance has accelerated sharply over the past five years.
Physician consolidation, the absorption of independent practices into hospital systems, health systems, private equity-backed physician management organizations, and large multi-specialty networks, has become the defining structural trend in American healthcare. The majority of U.S. physicians now work for a hospital or health system rather than an independent practice. In some specialties and markets, the independent physician has effectively ceased to exist as a meaningful category.
For healthcare marketers, this transformation is not a distant trend to monitor. It is an immediate reality that is making existing contact databases inaccurate, existing outreach strategies ineffective, and existing assumptions about who makes purchasing decisions in healthcare obsolete. The vendors who recognize this shift and adapt their data infrastructure and outreach approach accordingly are positioned to compete. The ones who do not are marketing into a reality that no longer exists.
The numbers behind physician consolidation are striking. According to the American Medical Association and multiple healthcare policy research organizations, the share of physicians working in physician-owned practices has declined from a clear majority to a minority over roughly a decade. Hospital and health system employment of physicians has grown correspondingly, as have employment by corporate entities including private equity groups and large management services organizations.
Private equity acquisition of physician practices has been particularly notable in high-volume specialties including dermatology, ophthalmology, gastroenterology, orthopedics, and primary care. In some of these specialties, PE-backed groups now control a significant share of practices in major metropolitan markets.
The implications for contact data are direct. When a private equity group acquires 20 independent dermatology practices across a metropolitan area and consolidates them under a single management structure, the purchasing decision for medical devices, software, supplies, and services moves from 20 independent decision-makers to a small number of corporate buyers. The physician-level contacts that represented the buying authority in those practices no longer have that authority for many categories of purchase.
At the same time, the administrative layer that now controls purchasing is often not well-represented in legacy physician contact databases. Those databases were built to reach physicians, not supply chain managers, group purchasing organization contacts, or corporate medical officers at PE-backed networks.
The contact data implications of physician consolidation operate on multiple levels, all of which degrade the usefulness of legacy healthcare marketing databases.
The most immediate problem is email address change. When a physician joins a health system or a consolidated group, their email address almost universally migrates to an institutional domain. The direct email they used as an independent practitioner is no longer valid for professional communications. Any database record pointing to that address is now a deliverability liability.
The second problem is role change. Physicians absorbed into large groups often take on administrative responsibilities that did not exist in their independent practice. A primary care physician who used to make all their own purchasing decisions may now operate within a system where procurement is handled by a group purchasing department. Their clinical preferences still matter for influence, but they no longer have direct purchasing authority.
The third problem is authority migration. The decision-maker for many product and service categories has moved out of the clinical layer entirely. Supply chain managers, VP-level administrators, chief medical officers at the group level, and in the case of PE-backed organizations, financial officers focused on margin optimization are now controlling categories that used to belong to individual physicians.
Legacy physician databases that were compiled when practices were independent do not capture this new authority structure. They have physician contacts with no indication that those physicians are now employees of a health system with centralized procurement, or that the relevant buying contact for the category is now a corporate administrator with no clinical training.
Effective healthcare marketing in a consolidated environment requires a two-layer contact strategy: clinical contacts for awareness, validation, and preference-setting, and administrative contacts for purchasing conversations.
At the clinical layer, physicians still matter enormously. Even in fully consolidated environments, clinical preference is a significant factor in purchasing decisions for medical devices, pharmaceutical choices within formulary constraints, and clinical software. A physician who advocates for a specific product within their health system creates pull that procurement teams respond to. Reaching physicians with clinical messaging that builds preference is still a necessary part of the marketing strategy.
But clinical preference without administrative access produces stalled deals. The physician who wants your product cannot always purchase it unilaterally. The contact who can approve the purchase is often a VP of Supply Chain, a Director of Procurement, a Chief Medical Officer at the group level, or in PE-backed organizations, a financial officer focused on cost optimization.
At large health systems, the C-suite is also relevant for strategic partnership conversations. Chief Medical Officers, Chief Strategy Officers, and VP-level operations executives make decisions about enterprise relationships that affect purchasing across dozens or hundreds of clinical sites.
Physician Data maintains verified contacts across all of these layers: physicians by specialty, practice setting, and geography; administrative decision-makers by role and institution type; and health system leadership by role and system size. The database is structured to support the two-layer outreach strategy that the consolidated healthcare environment requires.
Private equity's role in healthcare consolidation deserves specific attention because it creates a contact data challenge that is more complex than standard health system employment.
When a PE-backed organization acquires practices, the corporate structure typically involves a management services organization that sits above the clinical practices. The MSO handles contracting, procurement, human resources, and financial management for the practices under its umbrella. The physicians at the practice level remain the clinical operators, but the MSO controls the budget for most non-clinical purchases.
The relevant contacts at a PE-backed physician group are therefore not primarily the physicians. They are the MSO executives: the CEO of the management services organization, the VP of Operations, the Director of Procurement, and in some cases the private equity firm's operating partners who oversee the healthcare portfolio.
These contacts are not well-represented in legacy physician databases because they are relatively new roles created by the consolidation wave itself. Reaching them requires data sourcing approaches that specifically track the formation and growth of MSOs, not just the traditional physician directory sources.
The starting point for any healthcare marketer is an honest audit of their existing contact database. The question to ask is not whether the database contains physicians. It is whether those physician records reflect the current employment and authority structure of those physicians.
For records that pre-date 2020, the assumption should be that a meaningful percentage of contacts have transitioned from independent practice to some form of consolidated employment. The percentage will vary by specialty and geography, with higher rates of consolidation in urban markets and in specialties that have been most actively targeted by health systems and private equity.
For specialties where consolidation is most advanced, including dermatology, gastroenterology, and primary care in metropolitan markets, the audit should be aggressive. Assume that the purchasing authority structure has changed and that the administrative contact layer needs to be rebuilt.
For campaigns targeting product or service categories where clinical preference is the primary driver, the physician contact layer remains essential. But even for those campaigns, adding the administrative contact layer at the same institutions ensures that the physician advocacy created by the clinical outreach has a corresponding channel into the procurement decision.
Physician Data is structured to support this kind of layered outreach strategy. The database covers physicians by specialty, practice setting, and geographic market, and it covers the administrative and health system leadership contacts that represent the purchasing authority in consolidated environments. Clients can build lists that include both clinical and administrative contacts at the same institutions, enabling the coordinated outreach that consolidated healthcare purchasing requires.
Consolidation is genuinely disruptive to healthcare marketers who built their approach around the independent practice model. But disruption creates opportunity for the vendors who adapt.
Health systems acquiring new practices are actively standardizing their vendor relationships. When a health system absorbs a group of independent practices, those practices bring existing vendor relationships that the health system may or may not want to continue. Vendors who have relationships at the health system administrative level are positioned to win the standardization decision. Vendors who only have relationships at the individual practice physician level are vulnerable to being displaced.
New administrative leaders at consolidated groups are often open to vendor conversations that their predecessors were not. A new VP of Supply Chain at a PE-backed physician group is likely evaluating options across every category. Reaching them early in their tenure with accurate contact data and a relevant message is a significant competitive advantage.
And the growth of new consolidated organizations creates net new buying entities that did not exist before. A PE-backed dermatology group that has grown from 10 to 50 practices over the past three years represents a purchasing organization with scale that no individual practice in that network had previously. That scale creates demand for enterprise solutions across categories from practice management software to supply chain optimization to clinical data analytics.
Physician Data is built to help healthcare vendors reach the right contacts across the full spectrum of the consolidated healthcare market. To explore the database and request a sample, visit physician-data.com.
Charles Isham is the founder and CEO of K12 Data, Inc. and a portfolio of B2B data platforms covering education, healthcare, and government. A U.S. veteran with more than 15 years in education data, he oversees a database of more than 5 million verified contacts across K-20 education, healthcare, and public-sector verticals. He writes on data-driven outreach, hiring trends, and B2B marketing strategy. Reach him at Charlie@k12-data.com.
0
POST A COMMENT